St. Jude Medical/Epicor
This article was originally published in The Gray Sheet
Executive Summary
High Intensity Focused Ultrasound (HIFU) ablation device manufacturer Epicor is in the "final stages of generating and analyzing patient six-month follow-up data," St. Jude reports in a May 20 analyst update. St. Jude expects to resolve a $185 mil. purchase-option agreement this quarter, as Epicor has obtained 510(k) clearance for all components of the HIFU system, intended to treat atrial fibrillation (1"The Gray Sheet" May 5, 2003, p. 22)...